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Abstract 
Objectives: The main aim of this study was to assess the biological uptake of benzene and 
polycyclic aromatic hydrocarbons (PAHs) for subjects exposed to fresh crude oil released at 
sea. 
Methods: The study included 22 subjects participating in an «oil on water» field trial in the 
North Sea. Over two consecutive days there were six releases with two different types of 
fresh crude oils. Exposed subjects (N=17) were either located in small, open air boats 
downwind and close to the released oil (<50 m) or on the main deck of two large vessels 
further from the released oil (100-200 m). Subjects assumed to be unexposed (N=5) were 
located indoors on the command bridge of either vessel. Full-shift personal benzene 
exposure was monitored with passive thermal desorption tubes (ATD-tubes) packed with 
Tenax TA and subsequent gas-chromatographic analysis. Urine samples were collected 
before and after work-shift on both days and analyzed for urinary markers of benzene (S-
Phenyl Mercapturic Acid, SPMA) and PAHs (1-Hydroksypyrene, 1-OH). Information about the 
 
 
use of personal protective equipment, smoking habits, location, work tasks and length of 
work-shift was recorded by a questionnaire. 
Results: Subjects located in the small boats downwind and close to the released oil were 
exposed to relatively high concentrations of benzene (arithmetic mean=0.2 ppm, range 
0.002-1.5 ppm) compared to the occupational exposure limits (OELs) for 8 h (1 ppm) and 12 
h (0.6 ppm). Although respirators were available to all exposed subjects, SPMA was detected 
in post-shift urine (0.5-3.3 µmol/mol) of five exposed subjects reporting not wearing 
respirators, all located in the small boats downwind and close to the released oil. For 
exposed subjects wearing respirators (N=12) the post-shift urinary SPMA was below the 
detection limit (0.8 µmol/mol) even when the benzene exposure exceeded the OELs. Urinary 
levels of PAH were within the reference range of what is considered as background levels 
(<0.4 µmol/mol). 
Conclusions: During the initial stages of a bulk oil spill at sea, when the evaporation of 
benzene is at its highest, it is important to use appropriate respirators to prevent biological 
uptake of benzene. 
 





There is a potential health hazard for personnel participating in oil spill operations because 
of carcinogenic compounds that are present in fresh crude oil including benzene and 
polycyclic aromatic hydrocarbons (PAHs). Benzene is causally associated with hematotoxic 
and leukemogenic effects, also after exposure to low concentrations (Vlaanderen et al., 
2010; IARC, 2012; Health council of the Netherlands, 2014; ECHA, 2017; Loomis et al., 2017), 
while PAHs are causally associated with lung, skin and bladder cancer (IARC, 2010; Siddens et 
al., 2012).  
The main routes of human uptake for benzene and PAHs after occupational exposure are 
inhalation and skin contact. S-Phenyl Mercapturic Acid (SPMA) is a minor metabolite of 
benzene (about 1 % of total urinary benzene metabolites), but it is a specific and well-known 
urinary marker of benzene exposure (van Sittert et al., 1993; Farmer et al., 2005). SPMA is 
also reported to be a sensitive biomarker of benzene exposures as low as 0.1 ppm measured 
as a time-weighted average (TWA) of 8 h (Boogaard and van Sittert, 1996; Qu et al., 2000). 
Urinary 1-hydroxypyrene (1-OH), a metabolite of pyrene, has been widely used as a 
biomarker of exposure to PAHs (Jongeneelen et al., 1985; Jongeneelen, 2001).  
Information about benzene and PAH exposure levels during oil spills and cleanup 
operations and following biological uptake is scarce. Urinary measurements are easy to carry 
out and preferred over blood and exhaled air, however previous measurements during oil 
spills have been performed with metabolites that are poor markers of exposure to low 
concentrations (<1 ppm) of benzene (Lee et al., 2009; D'Andrea and Reddy, 2013). Lee et al. 
(2009) also measured metabolites of PAHs, but the urine samples were collected two weeks 
after the spill and therefore the measurements are not valid. In the most recent review of 
health effects after exposure to oil spills by Laffon et al. (2016) the authors conclude that 
 
 
there is also a lack of information about the effects of personal protective equipment (PPE) 
in preventing exposure to carcinogenic compounds.  
More knowledge is needed on benzene and PAH exposure levels, biological uptake and 
the effect of wearing PPE during cleanup of oil spills at sea. Thus, the aim of this study was to 
assess the concentration of urinary metabolites of benzene (SPMA) and PAHs (1-OH) before 
and after work-shift among personnel participating in an oil spill field trial at sea. 
 
Methods 
Oil release strategy 
The field trial was carried out during two consecutive days in June 2016 at the Frigg field in 
the North Sea, 150 km northwest of Stavanger, Norway. Two different types of fresh crude 
oils were released, one paraffinic ‘light crude oil’ (50°API) containing 1.02 wt% benzene, and 
one ‘heavy crude oil’ (26°API) containing 0.15 wt% benzene. In total there were six releases 
of oil with a minimum of 1 h between each release. Two releases of light crude oil (10 m3 
each) followed by three releases of heavy crude oil (4-6 m3 each) were performed on Day 1 
in calm winds (2-5 m/s) and no breaking waves. One release of light crude oil (10 m3) was 
performed on Day 2 in moderate winds (6-7 m/s) and breaking waves. 
 
Study population and location 
All personnel performing tasks in open air  on either of the five boats and vessels involved in 
the trial (Fig. 1) were invited to participate in the study (Exposed, N=18). However, one 
subject declined to participate, while two exposed subjects only participated on Day 1.  A 
 
 
few subjects not assumed to be exposed to benzene because they stayed indoor on the 
command bridge on the two vessels were also recruited (Background, N=5). 
Assumed personal exposure to benzene was assessed a priori, based on the location of 
the boats and vessels, resulting in three exposure groups; ‘High exposure’, ‘Low exposure’ 
and ‘Background’. Subjects in the ‘High exposure’ group (N=14) were located in three small, 
open air ‘Man Overboard’ (MOB) boats (5-8 m) located downwind and close to the released 
oil (<50 m). Personnel in these boats were in charge of air and oil sampling or navigation of 
the boats. Subjects in the ‘Low exposure’ group (N=8) were located on the main deck of two 
large vessels (75-93 m) in charge of oil release (Norwegian Coast Guard vessel) and oil spill 
response (Oil Recovery vessel). These vessels were located further from the released oil 
(100-200 m) and personnel on these vessels performed oil application and ship 
maintenance. Subjects in the ‘Background’ group (N=5) were located indoors on either of 
the large vessels doing observations and directing the trial. Five subjects were located a 
different place on Day 1 than on Day 2.  
PPE including disposable chemical protective overalls, nitrile gloves and half-face air 
purifying respirators with a combination of particle filter (P3) and organic vapor cartridge 
(A2) were available to all exposed subjects. Use of PPE was recommended by the company in 
charge of the field trial for personnel assumed to be exposed, but not mandatory. Smoking 
was prohibited in open air, but each vessel had a designated smoking room. The study was 
approved by the Western Norway Regional Committee for Medical Research Ethics. 






On both days the full-shift personal exposure to airborne benzene was measured with 
passive Tenax thermal desorption tubes (TD-tubes, Markes int/PerkinElmer, Boston, US-Ma). 
The methods and results are described by Gjesteland et al. (2017).  
 
Urine samples 
Each subject contributed with two urine samples on Day 1 and two urine samples on Day 2. 
One sample (pre-shift) was collected just before the work-shift started as a baseline 
measurement, while the other sample (post-shift) was collected just after the work-shift 
ended. Work-shifts varied between subjects from 5.2 to 14.6 h. Urine was collected in 
sample tubes (5 mL) containing concentrated hydrochloric acid (HCL, 5 µl) as a preservative 
and placed in protective cases. All samples were stored at 4°C, and shipped to the analyzing 
laboratory on ice. All subjects also answered a daily questionnaire before and after work-
shift about location, work tasks, length of work-shift, smoking habits and use of PPE. 
The urine samples were analyzed for SPMA, a urinary marker of benzene exposure, by 
high performance-liquid chromatography-mass spectrometry (HP-LC-MS-MS) with a limit of 
detection (LOD) of 10 nmol/L urine and roughly 0.8 µmol/mol creatinine (method OTOP37). 
The urine samples were also analyzed for 1-OH, a urinary marker of PAH exposure, by HP-LC-
fluorescence with an LOD of 1 nmol/L urine and roughly 0.1 µmol/mol creatinine (method 
OTOP09). Because benzene and PAHs are present in the main- and side stream cigarette 
smoke (Darrall et al., 1998; Johnson et al., 2007; Tombolini et al., 2018), cotinine, a urinary 
marker of direct or passive exposure to tobacco (Haufroid and Lison, 1998), was analyzed by 
LC-MS-MS with an LOD of 0.06 µmol/L urine. All samples were analyzed by the Health and 




Occupational exposure limits (OEL) and biological exposure indices (BEI) 
The Norwegian occupational exposure limits (OELs) for benzene is 1 ppm (8-h TWA) and 0.6 
ppm (12-h TWA) and the recommended biological exposure index (BEI) is 11.8 µmol 
SPMA/mol creatinine in end of shift urine (The Norwegian Oil and Gas Association, 2014). No 
Norwegian OEL for PAHs exist, but the ACGIH (2005) recommends a benchmark guideline of 
0.49 µmol 1-OH/mol creatinine in end of shift urine. 
 
Statistical analysis 
The results for the two days of sampling were merged in the descriptive analysis. SPMA was 
below the LOD in the majority of both the pre- (93%) and post-shift (83%) urine samples. 
Still, these samples were included in the analysis as the LOD/2 (0.4 µmol/mol creatinine), 
based on the average level of creatinine in urine (Hornung and Reed, 1990). The personal 
benzene exposure for the three exposure groups (High, Low and Background) is given as the 
arithmetic mean (AM) and range (minimum and maximum), in addition to the geometric 
mean (GM) and geometric standard deviation (GSD) due to highly skewed data. Differences 
between the three exposure groups were analyzed using one-way, independent measures, 
ANOVA. The correlation between airborne benzene exposure and post-shift urinary SPMA 
was analyzed by Pearson correlation after log transformation of the data. The results were 
also stratified by the use of respirator (yes/no) and tested for correlation. The level of 
significance was set to 0.05. SPSS Statistics 25 for Windows were used for analyzing the data 





A total of 22 subjects participated in the study, of whom 20 subjects participated both days 
(Table 1). The unexposed subjects were slightly older than the exposed subjects, and only 
one subject was female. Three subjects reported smoking, between 3 and 10 cigarettes/day. 
A total of 14 exposed subjects reported wearing respirators during the first hour after 
release of light crude oil, while five subjects, all located in the small boats downwind and 
close to the released oil, reported not wearing respirators. Subjects collecting oil samples 
reported use of gloves. On average the work-shifts lasted for about 10 h in each group, but 
with large variation within each group (Table 1). 
 
Personal benzene exposure and biological uptake 
A total of 42 full-shift personal air samples were collected and the AM and GM benzene 
exposure of all subjects was 0.2 ppm (range 0.002–1.5 ppm) and 0.05 (GSD=0.006), 
respectively (Table 2). The benzene exposure differed significantly between the three 
exposure groups (p<0.001), and the mean exposure (GM) was ten times higher for subjects 
in the ‘High exposure’ group compared to the ‘Low exposure’ group. 
One subject did not deliver a pre-shift urine sample on Day 1, resulting in a total of 41 
pre-shift and 42 post-shift urine samples (Table 2). Urinary SPMA was below the LOD in the 
majority of the samples (89%) and was only detected in pre-shift urine of three subjects 
(0.8–1.2 µmol/mol) and post-shift urine of five subjects (0.5–3.3 µmol/mol). The airborne 
benzene exposure and post-shift urinary SPMA concentration was not correlated (r= –0.005, 
p=0.98). 
Urinary 1-OH was detected in the urine of only three subjects (0.1–0.3 µmol/mol), all 
smokers. Cotinine was detected in both pre- (4.6–14.2 µmol/L) and post-shift (1.2–16.0 




Effect of respirators 
In Figure 2 the personal benzene exposure (upper three plots) and urinary concentration of 
SPMA (lower three plots) were stratified by the use of respirators (yes/no). The benzene 
exposure was significantly higher (p<0.02) for exposed subjects wearing respirators (AM=0.4 
ppm, range 0.003-1.5 ppm) compared to exposed subjects not wearing respirators (AM=0.1 
ppm, range 0.002-0.3 ppm).  
The benzene exposure on Day 1 and 2 for subjects wearing respirators (N=12) were 
merged (Fig. 2, upper left plot). Two subjects exceeded the 8-h OEL, while four subjects 
exceeded the 12-h OEL. Urinary SPMA was below the LOD for all of these subjects in both 
pre- and post-shift urine (Fig. 2, lower left plot), also for the cigarette smoker. 
For exposed subjects not wearing respirators (N=5) the benzene exposure (Fig. 2, upper 
right plots) was considerably higher (p=0.002) on Day 1 (AM=0.2 ppm, range 0.1–0.3 ppm) 
than on Day 2 (AM=0.006, range 0.002–0.01 ppm), but the OELs for benzene was not 
exceeded on either day. Urinary SPMA was detected in the post-shift urine (AM=1.9 
µmol/mol, range 0.5–3.3 µmol/mol) for all of these five subjects (Fig. 2, lower right plot), but 
was not significantly correlated (r=0.54, p=0.14) with the corresponding airborne benzene 
exposure.  
The highest concentration of SPMA (3.3 µmol/mol) was detected on Day 1, in the post-
shift urine of a non-smoker not wearing a respirator. Pre-shift urinary SPMA was detected 
for this subject on Day 2 (0.8 µmol/mol) and for the two smokers (10 cigarettes/day) not 





Personnel participating in the oil spill field trial were exposed to relatively high 
concentrations of benzene compared to the OELs with associated biological uptake. For 
exposed subjects wearing respirators SPMA was not detected in post-shift urine, even when 
the benzene exposure exceeded the OEL.  
For the five exposed subjects not wearing respirators in the small boats downwind and 
close to the released oil the full-shift exposure to benzene was below both the 8- and 12-h 
OEL and the urinary SPMA levels were below the recommended end of shift BEI. The average 
(AM) post-shift urinary SPMA concentration of these five subjects was 1.9 µmol/mol, while 
the average benzene exposure was 0.2 ppm. According to ECHA (2017) a benzene exposure 
of 0.2 ppm should correspond to a post-shift urinary SPMA concentration of about 3.9 
µmol/mol based on the mean half-life (9–13 h) of urinary SPMA (van Sittert et al., 1993; 
Boogaard and van Sittert, 1995; Qu et al., 2000). Although SPMA is suitable for biological 
monitoring of work-shifts longer than 8 h, the discrepancy between the SPMA levels of this 
study and the literature may be explained by that for some subjects the urine samples were 
collected more than 4 h after the exposure to benzene ended. 
Although previous studies have shown a correlation between benzene exposure and 
SPMA levels in post-shift urine (Qu et al., 2003; Farmer et al., 2005) there was no significant 
correlation in this study because of the use of respirators. There was a positive correlation 
(r=0.54) between benzene exposure and post-shift urinary SPMA among the five subjects 
not wearing respirators, but presumably due to low statistical power this association was not 
significant. 
Smoking may be a confounding factor at very low benzene exposure levels, but previous 
results are conflicting. A marked effect of smoking on urinary SPMA (0.2 µmol/mol per 
cigarette) in subjects not occupationally exposed to benzene was reported by Ghittori et al. 
 
 
(1999), while other authors report that smoking (up to 30 cigarettes/day) has no influence 
on the SPMA concentration (van Sittert et al., 1993; Waidyanatha et al., 2004; McNally et al., 
2017). Two exposed subjects not wearing respirators with detectable levels of SPMA in post-
shift urine were smokers (10 cigarettes/day). However, SPMA was also detected in the post-
shift urine of non-smokers, indicating that smoking was not the main source of urinary 
SPMA. 
For subjects wearing respirators the full-shift exposure to benzene ranged from 0.004 to 
1.5 ppm. However, the urinary SPMA levels among these subjects were below the LOD (<0.8 
µmol/mol), including the subject who reported smoking. This suggests that half-face air 
purifying respirators with a combination of particle filter (P3) and organic vapor cartridge 
(A2) prevents biological uptake of benzene during exposure to airborne benzene evaporating 
from a fresh crude oil released at sea.  
Only a few studies have investigated the biological uptake of benzene and PAHs during oil 
spill cleanup. Significant amounts of urinary phenol was measured among subjects 
participating in the cleanup of the Deepwater Horizon oil spill (D'Andrea and Reddy, 2013), 
however, phenol is an unspecific biomarker of benzene exposure (Boogaard and van Sittert, 
1995). No significant difference was found in metabolite levels of benzene and PAHs 
between subjects who wore respirators and those who did not during cleanup of the Hebei 
Spirit oil spill (Lee et al., 2009). However, urine samples were collected two weeks after the 
spill and not during the initial high exposure period. Also, the oil was a mix of heavy and 
medium crude oil (<32°API) with a low content of benzene. 
The sampling strategy was among the strengths of this study. The benzene exposure and 
uptake of individual subjects participating in the field trial was well documented by 
collecting full-shift air samples in addition to urine samples before and after work-shift. The 
 
 
study population was small due to a limited number of personnel participating in the field 
trial. However, repeated measurements of the study subjects over the two consecutive days 
allowed assessment of the urinary concentration over the time course of the sampling 
period. Furthermore, the questionnaires provided good documentation of the use of PPE 
(including respirators, gloves and disposable overalls), work tasks, beginning and end of 
work-shift, location and smoking habits. The results are relevant for personnel located 
downwind and close to a bulk spill of fresh oil during oil spill cleanup. 
The relatively long work-shifts (up to 15 h) may have affected the post-shift urinary SPMA 
levels because for some subjects the urine samples were collected several hours after the 
exposure to benzene ended. Also, the high number of samples with SPMA below the LOD, 
due to the use of respirators and low personal benzene exposure on Day 2, made it difficult 
to find significant trends between the benzene exposure and biological uptake.  
 
Conclusions 
The results of this study show that during the initial stages of a bulk oil spill at sea, when the 
evaporation of benzene is at its highest, it is important to use appropriate respirators to 
prevent biological uptake of benzene.  
 
Acknowledgements 
The study was performed as part of a competence and knowledge building project within the 
Research Council of Norway (RCN) PETROMAKS2 program. The project was funded through this 
program by RCN and the oil companies Aker BP, Centrica, ENI, Neptun Energy (previously Engie), 
Shell, Statoil and Total. SINTEF Ocean (previously SINTEF Materials and Chemistry) was project leader 
for the overall project.  
 
 
The authors would like to thank the Norwegian Clean Seas Association for Operating Companies 
(NOFO) and the Norwegian Coastal Administration (NCA) for allowing us to participate in the field 
trial. We thank Statoil for providing fresh crude oils, the Norwegian Coast Guard and NCA ship crew 
for arranging meals and accommodation, Erlend Sunde and Dan Krause for help with field work, and 
all study subjects for participation. We would also like to thank representatives from the oil 
companies, SINTEF Ocean and NOFO for valuable input through discussions and technical meetings. 
 
References 
ACGIH. (2005) Documentation of the TLVs and BEIs with Other Worldwide Occupational Exposure 
Values. Cincinnati, Ohio: American Conference of Governmental Industrial Hygienists 
(ACGIH). 
Boogaard PJ, van Sittert NJ. (1995) Biological monitoring of exposure to benzene: a comparison 
between S-phenylmercapturic acid, trans,trans-muconic acid, and phenol. Occup Environ 
Med; 52: 611-20. 
Boogaard PJ, van Sittert NJ. (1996) Suitability of S-phenyl mercapturic acid and trans-trans-muconic 
acid as biomarkers for exposure to low concentrations of benzene. Environ Health Perspect; 
104: 1151-57. 
D'Andrea MA, Reddy GK. (2013) Health consequences among subjects involved in Gulf oil spill clean-
up activities. Am J Med; 126: 966-74. 
Darrall K, Figgins J, Brown R. (1998) Determination of benzene and associated volatile compounds in 
mainstream cigarette smoke. Analyst; 123: 1095-101. 
European Chemical Agency. (2017) Proposal by the European Chemical Agency (ECHA) in support of 
occupational exposure limit values for benzene in the workplace, by European Chemical 
Agency, Helsinki, Finland, 34-38. 
Farmer PB, Kaur B, Roach J, Levy L, Consonni D, Bertazzi PA, Pesatori A, Fustinoni S, Buratti M, 
Bonzini M. (2005) The use of S-phenylmercapturic acid as a biomarker in molecular 
epidemiology studies of benzene. Chem-Biol Interact; 153: 97-102. 
Ghittori S, Imbriani M, Maestri L, Capodaglio E, Cavalleri A. (1999) Determination of S-
phenylmercapturic acid in urine as an indicator of exposure to benzene. Toxicol Lett; 108: 
329-34. 
Gjesteland I, Hollund BE, Kirkeleit J, Daling P, Bråtveit M. (2017) Oil Spill Field Trial at Sea: 
Measurements of Benzene Exposure. Ann Work Expo Health; 61: 692-99. 
Haufroid V, Lison D. (1998) Urinary cotinine as a tobacco-smoke exposure index: a minireview. Int 
Arch Occ Env Hea; 71: 162-68. 
Health council of the Netherlands. (2014) Benzene - Health-based recommended occupational 
exposure limit. The Hague: Health Council of the Netherlands. publication no. 2014/03. ISBN 
978 90 5549 988 5. 
Hornung RW, Reed LD. (1990) Estimation of Average Concentration in the Presence of Nondetectable 
Values. Applied Occupational and Environmental Hygiene; 5: 46-51. 
The International Agency for Research on Cancer (IARC). (2010) Some non-heterocyclic polycyclic 
aromatic hydrocarbons and some related exposures, by the IARC Monographs Working 
Group, Lyon, France, 92: 1-853. 
 
 
The International Agency for Research on Cancer (IARC). (2012) Chemical agents and related 
occupants, Benzene, by the IARC Monographs Working Group, Lyon, France, 100 F: 249-94. 
Johnson ES, Langård S, Lin Y-S. (2007) A critique of benzene exposure in the general population. Sci 
Total Environ; 374: 183-98. 
Jongeneelen FJ. (2001) Benchmark guideline for urinary 1-hydroxypyrene as biomarker of 
occupational exposure to polycyclic aromatic hydrocarbons. The Annals of Occupational 
Hygiene; 45: 3-13. 
Jongeneelen FJ, Anzion RBM, Leijdekkers C-M, Bos RP, Henderson PT. (1985) 1-Hydroxypyrene in 
human urine after exposure to coal tar and a coal tar derived product. Int Arch Occ Env Hea; 
57: 47-55. 
Laffon B, Pásaro E, Valdiglesias V. (2016) Effects of exposure to oil spills on human health: updated 
review. J Toxicol Env Health B; 19: 105-28. 
Lee SM, Ha M, Kim EJ, Jeong WC, Hur J, Park SG, Kwon H, Hong YC, Ha EH, Lee JS. (2009) The effects 
of wearing protective devices among residents and volunteers participating in the cleanup of 
the Hebei Spirit oil spill. J Prev Med Public Health; 42: 89-95. 
Loomis D, Guyton KZ, Grosse Y, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Vilahur N, 
Mattock H, Straif K. (2017) Carcinogenicity of benzene. The Lancet Oncology; 18: 1574-75. 
McNally K, Sams C, Loizou GD, Jones K. (2017) Evidence for non-linear metabolism at low benzene 
exposures? A reanalysis of data. Chem-Biol Interact; 278: 256-68. 
Qu Q, Melikian AA, Li G, Shore R, Chen L, Cohen B, Yin S, Kagan MR, Li H, Meng M. (2000) Validation 
of biomarkers in humans exposed to benzene: urine metabolites. Am J Ind Med; 37: 522-31. 
Qu Q, Shore R, Li G, Jin X, Chen LC, Cohen B, Melikian AA, Eastmond D, Rappaport S, Li H, et al. (2003) 
Validation and evaluation of biomarkers in workers exposed to benzene in China. Res Rep 
Health Eff Inst; 1-72; discussion 73-87. 
Siddens LK, Larkin A, Krueger SK, Bradfield CA, Waters KM, Tilton SC, Pereira CB, Löhr CV, Arlt VM, 
Phillips DH, et al. (2012) Polycyclic aromatic hydrocarbons as skin carcinogens: Comparison of 
benzo[a]pyrene, dibenzo[def,p]chrysene and three environmental mixtures in the FVB/N 
mouse. Toxicology and applied pharmacology; 264: 377-86. 
The Norwegian Oil and Gas Association. (2014) 131– Norwegian Oil and Gas Recommended 
guidelines for identification, assessment, control and follow-up of benzene exposure, by The 
Norwegian Oil and Gas Association, Page 5. 
Tombolini F, Pigini D, Tranfo G, Paci E, Carosi I, Marini F, Bauleo L, Ancona C, Forastiere F. (2018) 
Levels of urinary metabolites of four PAHs and cotinine determined in 1016 volunteers living 
in Central Italy. Environmental Science and Pollution Research. 
van Sittert NJ, Boogaard PJ, Beulink GD. (1993) Application of the urinary S-phenylmercapturic acid 
test as a biomarker for low levels of exposure to benzene in industry. Brit J Ind Med; 50: 460-
69. 
Vlaanderen J, Portengen L, Rothman N, Lan Q, Kromhout H, Vermeulen R. (2010) Flexible meta-
regression to assess the shape of the benzene-leukemia exposure-response curve. Environ 
Health Perspect; 118: 526. 
Waidyanatha S, Rothman N, Li G, Smith MT, Yin S, Rappaport SM. (2004) Rapid determination of six 
urinary benzene metabolites in occupationally exposed and unexposed subjects. Analytical 
Biochemistry; 327: 184-99. 
 
 






Table 1. Review of questionnaire presented by the three exposure groups. 
  Exposure 
group Location 







shift, h (range)   Day 1 Day 2 
Unexposed 
(N=5)  Background Indoors 5 5 45 (32-63) 0 0 10.1 (5.3-14.6) 
Exposed 
(N=17) 
Low Vessels  4 7 34 (18-57) 1 5 9.8 (5.2-12.5) 
High Small boats 13 8 38 (18-58) 2 9 10.6 (5.2-14.3) 





Figure 2. Upper three plots: Full-shift benzene exposure (ppm) on a log scale measured with ATD. The OEL for benzene of 8 h (solid line) and 12 h (stapled line) is included. 
Lower three plots: Concentration of SPMA in pre- and post-shift urine (µmol/mol) on a log scale. The LOD/2 is included (stapled line) and cigarette smokers are indicated by 
dotted interpolation lines. The ‘Background’ group is not included. 
Table 2. Environmental and urinary concentration of benzene (ppm) and SPMA (µmol/mol creatinine), 
respectively, for study subjects (N=22) stratified by exposure group.  
  Exposure Subjectsa Samples 
<LOD AMb (range) GM GSD p 
  group (N) (n) 
Full-shift Background 5 10 0 0.01 (0.004-0.03) 0.007 0.006 
0.001 personal benzene Low  8 11 0 0.05 (0.002-0.1) 0.02 0.07 
exposure (ppm) High 14 21 0 0.4 (0.01-1.5) 0.2 0.4 
                  
Pre-shift  Background  5 10 10 ND - - 
0.23 urinary SPMA  Low  8 11 11 ND - - 
(µmol/mol) High  14 20 17 0.5 (ND-1.2) 0.5 0.4 
                  
Post-shift  Background  5 10 10 ND - - 
0.31 urinary SPMA  Low  8 11 10 0.5 (ND-1.5) 0.5 0.4 
(µmol/mol) High  14 21 16 0.8 (ND-3.3) 0.5 0.5 
LOD: limit of detection, AM: arithmetic mean, GM: geometric mean, GSD: geometric standard deviation, SPMA: 
S-phenylmercapturic acid, ND: not detected 
aA few subjects were located a different place on Day 1 than on Day 2, see table 1 for distribution. 
bThe AM, GM and GSD was calculated by including samples with SPMA below the LOD as the LOD/2. 
 
 
 
